Nonionic block copolymers potentiate activities of drugs for treatment of infections with Toxoplasma gondii.

Antimicrobial Agents and Chemotherapy
Fausto G Araujo, Teri Slifer

Abstract

We studied the interaction between drugs and the nonionic block copolymers CRL 8131 and CRL 8142 in the treatment of toxoplasmosis in murine models of the disease. Treatment of acute toxoplasmosis with copolymers alone caused slight prolongation of time to death but not survival. In contrast, significant survival occurred when mice were treated with either copolymer combined with doses of sulfadiazine, pyrimethamine, clindamycin, or atovaquone, which did not prevent mortality when used alone. Treatment with CRL 8131 plus sulfadiazine or pyrimethamine resulted in 50 or 40% survival, respectively. Treatment with the same copolymer plus a dose of clindamycin that protected 40% of the mice when used alone resulted in 100% survival. Treatment of toxoplasmic encephalitis with CRL 8131 plus an ineffective dose of atovaquone reduced the inflammation and numbers of Toxoplasma gondii cysts in the brain. Studies to investigate the drug-enhancing activity of CRL 8131 revealed that mice immunized with toxoplasma lysate plus copolymer had lymphocyte proliferation responses to T. gondii antigens significantly higher than those in mice immunized with lysate alone. Challenge of immunized mice with a lethal inoculum of T. gondii resulted in sign...Continue Reading

References

Aug 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B J Luft, J S Remington
Feb 1, 1992·Antimicrobial Agents and Chemotherapy·F G AraujoJ S Remington
Sep 1, 1990·Infection and Immunity·Y SuzukiJ S Remington
Dec 1, 1984·The Journal of Infectious Diseases·R E McCabeJ S Remington
Jan 1, 1981·International Archives of Allergy and Applied Immunology·H SnippeR L Hunter
Jan 1, 1994·Biotherapy·C A HunterJ S Remington
Nov 1, 1994·The Journal of Infectious Diseases·C A Hunter, J S Remington
Mar 1, 1994·Antimicrobial Agents and Chemotherapy·F G AraujoJ S Remington
Nov 1, 1993·Antimicrobial Agents and Chemotherapy·J L KrahenbuhlL Gu
Mar 1, 1993·AIDS·S Y Wong, J S Remington
Jan 1, 1992·International Journal of Antimicrobial Agents·F G Araujo, J S Remington

❮ Previous
Next ❯

Citations

Jul 18, 2000·Antimicrobial Agents and Chemotherapy·S EspuelasJ M Irache
Dec 3, 1999·Antimicrobial Agents and Chemotherapy·C JagannathR L Hunter

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.